Endomag

Endomag was founded to solve healthcare challenges through the application of advanced magnetic sensing technology. The SentiMag® and Sienna+® device system was developed to increase access to the standard of care in breast cancer staging by providing an alternative approach to locating sentinel lymph nodes. The Endomag system avoids the requirement for traditional radioisotopes in sentinel lymph node biopsy (SLNB), improving workflow and costs while increasing availability of the standard of care. Endomag is also developing a pipeline of associated devices that improve the standard of breast cancer management along with extending the reach of SLNB for other cancers.